News

A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains which developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.

Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).

As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

UCLH is to trial a COVID-19 vaccine developed by Imperial College London.

Researchers have highlighted the importance of routinely screening healthcare staff for SARS-CoV-2 after finding a high proportion of frontline staff had the virus at the peak of the pandemic.

Could dogs offer quick and effective diagnosis of COVID-19?

Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.